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Introduction
With the increased recognition that healthcare eval-
uations should incorporate patients’ perspectives,
the focus of outcome in stroke research has shifted
from mere survival and disability to the inclusion of
patient-reported health rating scales. Especially in
those patients surviving with no or minor sequelae
from their original TIA or minor ischaemic stroke
(MIS) outcome measures other than disability grades
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j Abstract Background Stroke
has a major impact on survivors.
Our study was designed to de-
scribe the mental status and
health-related quality of life (HR-
QoL) in long-term survivors of
TIA or minor ischaemic stroke
(MIS) and evaluate associations of
mental and physical factors with
HR-QoL. Methods A random
sample of the 10-year survivors of
the Dutch TIA Trial (DTT) and the
dutch participants of the European
Atrial Fibrillation Trial (EAFT)
were interviewed by postal ques-
tionnaire (n = 468) and at home
(n = 198). Demographic data,
mental health status (depression
(CES-D), cognition (CAMCOG)),
and health perception (SF-36 and
Euroqol) were measured. Results
198 long-term survivors were in-
cluded; mean age was 72.5 (SD
8.7 years), 22% was depressed
(CES-D ‡ 16) and 15% had cog-
nitive dysfunction (CAM-
COG < 80). The overall HR-QoL
did not differ much from the norm
population. Physical disability,
occurrence of a major stroke and
comorbidity of locomotion or the
heart were independently associ-
ated with a low health perception.
Conclusions Despite varying
amounts of disability, the majority
of long-term survivors of a TIA or
MIS rated their quality of life as
rather good. Physical factors,
rather than mental status were
independently related to a de-
crease in perceived health.
j Key words mental status Æ
health-related quality of life Æ
cerebral ischaemia Æ
comorbidity
A. Algra, MD
For the Life Long After Cerebral
Ischaemia Study Group
Julius Centre for Health Sciences and
Primary Care
University Medical Centre Utrecht
Utrecht, The Netherlands
A. Algra, MD (&)
For the Life Long After Cerebral
Ischaemia Study Group
Dept. of Neurology and Julius Centre
University Medical Centre
Utrecht Str 6.131
P.O. Box 85500
3508 GA Utrecht
The Netherlands
Tel.: +31-30/2509350
E-Mail: a.algra@umcutrecht.nl
ORIGINAL COMMUNICATION
J Neurol (2007) 254:1018– 1025
DOI 10.1007/s00415-006-0480-9
*See for investigators Dutch TIA Trial
(neurologists of centres with ‡50 patients)
appendix NEJM, 1990: 325; 1260, and for
investigators from Dutch centres of the
EAFT appendix Lancet, 1993: 342; 1262.
I. van Wijk, MD Æ L.J. Kappelle, MD
J. van Gijn, MD, FRCP Æ A. Algra, MD
Dept. of Neurology
Rudolf Magnus Institute of Neuroscience
University Medical Centre Utrecht
Utrecht, The Netherlands
I. van Wijk, MD Æ J.W. Gorter, MD
E. Lindeman, MD
Dept. of Rehabilitation
University Medical Centre Utrecht and
Rehabilitation Centre De Hoogstraat
Utrecht, The Netherlands
P.J. Koudstaal, MD
Dept. of Neurology
Erasmus Medical Centre
Rotterdam, The Netherlands
are particularly relevant. The International Classifi-
cation of Functioning, Disability and Health (ICF) [1],
published by the WHO in 2001 as a model for the
description of the components of health, has been
used widely as a theoretical framework for outcome
research (Fig. 1). Although the ICF-frame work
addresses many aspects of functioning and health it
does not cover patients’ subjective feelings of physi-
cal, psychological and social well-being [2]. Another
construct used for research is the WHO ‘‘biopsycho-
social model’’ of health [3], in which health is defined
as a state of complete physical, mental and social well-
being, and not merely the absence of diseases and
infirmity. This WHO definition of health is seen by
many researchers as synonymous to ‘‘Health-Related
Quality of life’’ (HR-QoL) [4]. Although physical
disability and QoL are often related, there are
exceptions. A study from New Zealand, for example,
found that 6 years after stroke HR-QoL (as measured
with the SF-36) was relatively good [5], whereas a
Finnish study showed that stroke patients with little
or no physical dysfunction can experience a com-
promised QoL [6]. Psychological factors appear to be
as important as physical disability in determining
QoL [7]. To date, no precise information is available
about the long-term mental status of patients with a
history of TIA or MIS, nor about the relation between
these mental factors, the physical factors and the
patients’ perception of their current health state.
We studied a cohort of about 200 elderly with a
history of transient or limited cerebral ischaemia for:
(1) their mental status, (2) their HR-QoL and (3)
associations of physical and mental factors with
health perception.
Subjects and methods
j Study population
LiLAC (Life Long After Cerebral ischemia) is a cohort study based
on the study populations of the Dutch TIA Trial (DTT) and the
European Atrial Fibrillation Trial (EAFT. Patients who had a TIA or
MIS were included in these trials. A neurologist in any of the par-
ticipating hospitals made the diagnosis. Important inclusion criteria
were: the TIA (symptoms lasting for less than 24 h) or MIS should
have been within three months before randomisation, and patients
had to be independent in most of their daily activities (modified
Rankin Score (mRS) 3 or less); details have been described else-
where [8–10]. In the DTT 3150 patients were included; a cardiac
origin of the ischemic event and disorders of blood coagulation were
exclusion criteria. For LiLAC we included only patients from centres
that had randomised 50 patients or more in the DTT (n = 2473). In
the EAFT 1007 patients were included; current (<2 years) atrial
fibrillation (confirmed by electrocardiography) was a prerequisite.
For LiLAC we only included the Dutch participants (n = 186).
In the present study the follow-up of all patients alive at the end
of the DTT and EAFT was extended to the period between March
2001 and December 2003; 1024 of the 2659 eligible patients survived
(Fig. 2). With a computer-generated list we contacted a random
sample of survivors, aiming at 200 participants for a homevisit.
From the 468 who were willing to participate we drew another
random sample. All patients gave written informed consent and the
ethics committee of the University Medical Centre Utrecht ap-
proved the study protocol.
j Measurements
Baseline characteristics (medical history, event characteristics and
data from ECG’s and CT-scanning) were systematically recorded
in both trials. We obtained information about living condition
(independent or protected, alone or with partner), comorbidity
and health perception (EuroQoL) by means of a postal ques-
tionnaire.
Comorbidity was assessed with a predefined structured list
comprising a broad range of diseases within the following cate-
gories: cardiac, respiratory, diabetes, neurological, locomotor
system, cancer, visual system, hearing system or otherwise
(appendix 1). The list was composed on the basis of a known or
assumed high burden of illness [11]. Patients also had to state
whether they still received medication or therapy for a specific
disease and whether they believed this disease influenced their
daily functioning.
The Euroqol was used as a generic instrument [12], providing
a simple, descriptive profile of health in five dimensions (mobility,
self-care, social, pain, and psychological), with the possibility to
create a single index score. The Euroqol also includes a visual
analogue scale (VAS) on which patients rate their own health
between 0 and 100. It is generally recommended to use it together
with more detailed generic measures [12] such as the SF-36, which
we therefore included in the structured interview for the home
visit.
The homevisit-interview was undertaken by trained research
assistants to get information about the mental (cognition and
depression) status and HR-QoL (SF-36). The SF-36 is a short
(10 minutes), valid and efficient instrument to describe health
perception in 8 domains (physical functioning, physical role
limitation, emotional role limitation, social functioning, mental
health, vitality, pain and general health) [13]. The psychometric
qualities of the SF-36 and the Euroqol have been tested in stroke
populations [13, 14] and in a random Dutch population sample
[15, 16].
For the evaluation of cognitive function the Dutch version of the
CAMCOG was used [17]. The CAMCOG is the cognitive and self-
contained part of the Cambridge Examination for Mental Disorders
of the Elderly (CAMDEX) [18], a standardized instrument for
the diagnosis and grading of dementia. It consists of 67 items, divided
over the subscales orientation, expressive and comprehensive
ICF = International Classification of Functioning, Disability and Health. 
Body functions
Environmental factors
Activities
Personal factors 
Participation 
Health condition 
Fig. 1 Schematic survey of the framework of the ICF
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language, memory, attention, praxis, calculation, abstraction and
perception, with a range of 0–107. It has been shown stable and
reliable and also suitable to distinguish well between normal cogni-
tive functioning and mild cognitive impairment [19]. In contrast to
the MMSE it has little ceiling effect in non-demented elderly [20].
Despite its length it appeared to be feasable in elderly stroke patients
[21, 22] In most studies a cut-off point of 79/80 was used between
demented patients and normal subjects [18].
For the evaluation of symptoms of depression we used the
Centre for Epidemiological Studies of Depression (CES-D) scale
[23]. Scores range from 0 to 60, with higher scores indicating more
severe symptoms. A score of 16 or higher is considered indicative
of depression [24].
If a patient could not be interviewed a proxy (usually the
spouse) provided answers. For most measurement instruments
proxy ratings have shown to be valid and reliable.
Finally, the research assistant evaluated the functional depen-
dence in self-care and mobility of the patient by means of the
modified Rankin Score [25].
j Data analysis
The primary aim of the data analysis was the description of long-
term mental status and HR-QoL of survivors of limited cerebral
ischemia. Therefore, descriptive statistics (parametric and non-
parametric) were used according to the characteristics of the
measurement instruments. Where available, scores were compared
with standard norm scores for the Dutch population of the same
age. Associations of independent variables with perceived health
were tested with the independent samples t-test. Variables that had
a statistically significant association with perceived health (VAS-
score; p < 0.05) were entered into a multivariate linear regression
model.
Results
Of the 838 patients who were contacted (Fig. 2) 468
agreed to participate, 126 refused, 39 had died and
205 did not respond. Those who did not respond, died
or refused to participate were older (62 years vs.
57 years), more often female (41% vs. 35%) and had
more often a minor stroke rather than a TIA (64% vs.
58%), or white matter lesions on baseline CT scan
(7% vs. 3%). The other characteristics presented in
Table 1 did not differ between participants and non-
participants. Those who were willing to participate
were contacted again in a random fashion until 198
patients had been actually visited at home (Fig. 2).
j Demographics
The mean age at the time of the home visit was
72.5 years (SD 8.7). Patients who participated in the
home visit were younger, more often had had a TIA
and had fewer vascular risk factors at baseline than
the average participant in the LiLAC study (Table 1).
After a mean follow-up of 15.6 years (SD 1.1) only 5–
7% of the responding survivors were institutionalised;
the majority was living with a partner (Table 1).
j Mental status
In eight patients the data on cognitive functioning
were not sufficient for analysis: four because of visual
problems, two because of writing problems, and two
for unknown reasons. Therefore 190 patients re-
mained in the analysis of the CAMCOG data. The
median total score was 91 (Interquartile Range (IQR)
84–95); no one reached the maximum score. Lowest
scores were obtained for the domains abstract
thinking, perception and memory.
41 of 190 (21.5%) patients were depressed (CES-D
score 16 or higher). The median score of all partici-
pants on the CES-D was 13 (IQR 10–16) (Table 1).
j Co-morbidity
About 147 (75%) participants reported one or more
co-existing diseases, most often in the category car-
diac disease (36%) or problems with locomotion
(35.4%) (Table 1, Appendix).
DTT = Dutch TIA Trial, EAFT = European Atrial Fibrillation Trial 
random sample 
willing to participate 
random sample 
selected for home visit 
2659 at start of DTT/EAFT
1024 alive 1635  died
838 
468 
198 
Fig. 2 Flow diagram
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j Health-related quality of life
The mean VAS score was 72.5 (SD 19.1) and mean
Euroqol index score 0.72 (0.26) (Table 2). The
majority of patients experienced problems in the
dimensions mobility (61%) and pain/discomfort
(63%) of the Euroqol, while only a few reported
problems in self-care (15%). These percentages were
higher than in the Dutch norm population (age
group 70–79 years). The VAS-score, index score
and the scores on the SF-36 dimensions did not
differ significantly from norm scores for age
(Table 2).
Both mental and physical factors were related to
health perception (Table 3). Factors independently
related to a poor perception of health (VAS-score)
in the multivariate analysis were functional depen-
dence in self-care and mobility by means of the
modified Rankin Score (mRS) >2, the presence of
comorbidity and the recurrence of a major stroke
(Table 4).
Discussion
In this study of patients with transient or minor
ischaemic stroke we found that after an average
period of 15.6 years, one out of five of the surviving
patients (mean age 72.5, SD 8.7 years) visited at
home was depressed, 15% had cognitive dysfunc-
tion, and 5.3% suffered from both conditions. Yet,
patients’ own health rates were generally similar to
that of a norm population. A negative health per-
ception was associated with functional dependence
in self-care and mobility, the occurrence of a major
stroke and comorbidity affecting locomotion or the
heart.
We used a patient-centred approach to describe
the health status of our elderly population. The
importance of obtaining patients’ own views on Qol
has been emphasised [26] and therefore we used the
VAS-score of the Euroqol as outcome measure in the
multivariate regression analysis. Moreover, standar-
dised measurement instruments were used to describe
the mental status and HR-QoL, which facilitates
interpretation of data and allows comparison with
other studies. In addition, we studied associations of
both physical and mental factors with perceived
health.
Our patients experienced considerably more
problems in the five dimensions of the EuroQol than
the general Dutch population [15]. The mean VAS
was only slightly lower than that of a UK norm pop-
ulation [27]. The SF-36 was used for evaluating long-
term Qol after stroke in the Auckland population
Table 1 Characteristics of different groups
characteristic Total
(n=2659)
Home visits
(n=198)
At baseline
Female 35.5 32.8
Age at randomisation (m, SD) 65.6 (10.1) 56.9 (8.7)
Minor stroke vs TIA 69.8 55.1
Diabetes 8.3 3.6
Intermittent claudication 5.1 2.1
Hypertension 42.1 34.9
Myocardial infarction 10.4 7.2
Modified Ranking Score>=2 24.2 13.2
Any infarct on CT scan 41.4 26.6
White matter lesions 11.6 2.7
At follow up
New vascular event 55.4 26.7
Age at homevisit (m, SD) NA 72.5 (8.7)
Institutionalized NA 5.2
Living alone NA 31.1
Comorbidity NA
Cardiac 36.4
Respiratory 16.7
Diabetes 17.0
Neurologic* 12.1
Locomotion 35.4
Cancer 3.9
Visual 10.1
Auditive 15.2
Other 21.7
Depression (CES-D >=16) NA 21.5
Cognitive dysfunction (CAMCOG < 80) NA 15.3
Modified Rankin Score >=2 NA 25.8
N = number of patients. Figures are percentages unless otherwise stated. m =
mean, SD = standard deviation, NA = not available. *only diseases other than
TIA or stroke were counted.
Table 2 Health-related quality of life
Patients Pop Norms*
Eurogol
VAS-score (mean, SD) 73 (19) 76 (21)
Reporting any problems in
Mobility (%) 61 43
Self-care (%) 15 9
Usual activities (%) 35 23
Pain/discomfort (%) 63 42
Anxiety/depression (%) 25 12
SF-36 (mean, SD)
Physical Functioning 68 (37) 70 (27)
Role Physical 78 (38) 70 (41)
Bodily Pain 79 (25) 81 (24)
General Health 63 (23) 64 (18)
Vitality 72 (22) 69 (22)
Social Functioning 89 (20) 83 (23)
Role Emotional 94 (22) 82 (35)
Mental Health 84 (16) 79 (14)
*figures present Dutch population norms for the same age group, except for
the Euroqol VAS-score (UK-population norms).
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6 and 21 years after stroke [5, 28]. Six years after
stroke these patients scored lower than population
norms in the dimensions vitality, physical function-
ing, general health, and social functioning, while the
SF-36 profile of the 21-year survivors was broadly
similar to that of the general population. The
researchers concluded that the overall QoL was rela-
tively good. Our population also rated their QoL
approximately the same as its reference group [29]. It
is known that psychological adaptation among
patients with chronic medical conditions is effective
[30], and, like in the Auckland studies, we conclude
that this occurred in our elderly population too. In
contrast, HR-Qol (SF-36) in young patients (15–
45 year) with ischaemic stroke was still appreciably
compromised in a hospital-based study from Iowa,
6 years after stroke [31].
We found a univariate association between
depressive symptoms and perceived health (VAS-
score), in agreement with other studies [26, 32, 33].
However, depression did not prove an independent
determinant of a poor health perception in the mul-
tivariate analyses. Association between cognitive
dysfunction and health perception has been assumed
[7], but in a recent studies from Amsterdam and
Edingburgh cognitive impairment was not an inde-
pendent explanatory factor for poor QoL or satisfac-
tion with life in old age, respectively [34, 35]. The
association we found between physical disability and
decreased QoL has been established before [33, 34,
36].
A potential limitation in the interpretation of our
results is that we were dealing with a highly selected
cohort of patients, in that they (1) were referred to
hospital, (2) consented to participate in a trial, (3)
survived for an average period of about 15 years, and
(4) consented to participate in the home visit. Al-
though survivors who participated in the home visit
did not appreciably differ in baseline cardiovascular
risk factors from those who declined, they probably
represent the surviving fittest. We therefore believe
that the health problems perceived by our study
group represent the lower limit of the true range of
problems in the elderly with a history of limited
cerebral ischaemia.
In an aging population, with an increase in car-
diovascular and co-existing diseases, this information
can be useful for medical professionals and health-
care officials.
Another limitation is that we were not able to re-
cord all the reasons for non-response; cognitive
impairment or depression may have played a role,
each possibly related to the outcome measure we
studied.
We acknowledge that the accuracy of the diagnosis
TIA is limited, but this would apply to future patients
with TIA(like) symptoms as well, hence we do not
think that this issue hinders the generalisability of our
findings.
When patients were not communicative, informa-
tion from proxies was used. Generally there is good
agreement between QoL assessment by patients and
family caregivers [37], but the caregivers’ responses in
some domains should be interpreted with care [38].
The advantages of including proxy responses proba-
bly outweigh the resulting loss of information when
they are excluded.
In a study of specific events in this cohort we
found that patients continue to have an elevated risk
of death and new vascular events, and should con-
tinue to pay attention to lifestyle and drug compli-
ance [10]. It now seems that the surviving fittest, are
able to maintain acceptable levels of health status
and subjective well-being, despite certain limitations
in their daily activities. Although mental factors did
not influence quality of life in multivariate analysis,
it did in the univariate analysis, therefore we suggest
that it is important to detect and manage symptoms
of depression in these patients. In addition, inter-
vention strategies should be focused on the pre-
vention of recurrent stroke and treatment of
coexisting diseases of the heart and locomotor
system.
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Table 4 Results of multivariate linear regression analysis with health
perception (VAS-score)
Multivariate regression
Variable B(b coefficient) 95% Cl
Recurrent stroke )8.2 )14.3 to )2.2
Comorbidity cardiac )8.6 )13.5 to )3.7
Comorbidity Iocomotion )5.4 )10.6 to )0.1
Rankin Scale Score > 2 )18.6 )24.5 to )12.7
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Appendix
Structured list of coexistent diseases
Category Diseases
Cardiac Heart failure
Myocardial infarction
Arrhythmia
Angina
Other
Pulmonary Asthma
Chronic bronchitis
COPD
Other
Diabetes
Neurologicala Stroke before 1990/1993
Stroke after 1990/1993
Multiple sclerosis
Amyotrofic lateral sclerosis
Polyneuropathy
Other
Locomotor system Amputation of lower extremity
(Rheumatoid) arthritis/arthrosis
Hip or knee replacement
Chronic back pain
Other
Cancer
Visual system Total blindness
Very low vision
Blindness of one eye
Auditive system Total deafness
Very bad hearing
Other
aIn the analyses on comorbidity only neurologic diseases other than stroke were
counted
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